Literature DB >> 24742808

Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma.

D Y Kim1, J H Lee2, M J Goh1, Y S Sung1, Y J Choi1, R G Yoon1, S H Cho1, J H Ahn3, H J Park3, J H Baek1.   

Abstract

BACKGROUND AND
PURPOSE: The increased cochlear signal on FLAIR images in patients with acoustic neuroma is explained by an increased concentration of protein in the perilymphatic space. However, there is still debate whether there is a correlation between the increased cochlear FLAIR signal and the degree of hearing disturbance in patients with acoustic neuroma. Our aim was to investigate the clinical significance of an increased cochlear 3D FLAIR signal in patients with acoustic neuroma according to acoustic neuroma extent in a large patient cohort.
MATERIALS AND METHODS: This retrospective study enrolled 102 patients with acoustic neuroma, who were divided into 2 groups based on tumor location; 22 tumors were confined to the internal auditory canal and 80 extended to the cerebellopontine angle cistern. Pure tone audiometry results and hearing symptoms were obtained from medical records. The relative signal intensity of the entire cochlea to the corresponding brain stem was calculated by placing regions of interest on 3D FLAIR images. Statistical analysis was performed to compare the cochlear relative signal intensity between the internal auditory canal acoustic neuroma and the cerebellopontine angle acoustic neuroma. The correlation between the cochlear relative signal intensity and the presence of hearing symptoms or the pure tone audiometry results was investigated.
RESULTS: The internal auditory canal acoustic neuroma cochlea had a significantly lower relative signal intensity than the cerebellopontine angle acoustic neuroma cochlea (0.42±0.15 versus 0.60±0.17, P<.001). The relative signal intensity correlated with the audiometric findings in patients with internal auditory canal acoustic neuroma (r=0.471, P=.027) but not in patients with cerebellopontine angle acoustic neuroma (P=.427). Neither internal auditory canal acoustic neuroma nor cerebellopontine angle acoustic neuroma showed significant relative signal intensity differences, regardless of the presence of hearing symptoms (P>.5).
CONCLUSIONS: The cochlear signal on FLAIR images may be an additional parameter to use when monitoring the degree of functional impairment during follow-up of patients with small acoustic neuromas confined to the internal auditory canals.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 24742808      PMCID: PMC7966264          DOI: 10.3174/ajnr.A3936

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience.

Authors:  D F Kallmes; F K Hui; J P Mugler
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

2.  Optimized single-slab three-dimensional spin-echo MR imaging of the brain.

Authors:  J P Mugler; S Bao; R V Mulkern; C R Guttmann; R L Robertson; F A Jolesz; J R Brookeman
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

3.  Fast spin echo sequences with very long echo trains: design of variable refocusing flip angle schedules and generation of clinical T2 contrast.

Authors:  Reed F Busse; Hari Hariharan; Anthony Vu; Jean H Brittain
Journal:  Magn Reson Med       Date:  2006-05       Impact factor: 4.668

4.  Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma.

Authors:  Masahiro Yamazaki; Shinji Naganawa; Hisashi Kawai; Takashi Nihashi; Hiroshi Fukatsu; Tsutomu Nakashima
Journal:  Neuroradiology       Date:  2009-12       Impact factor: 2.804

5.  Labyrinthine tap as a diagnostic test for acoustic neurinoma.

Authors:  H Silverstein
Journal:  Otolaryngol Clin North Am       Date:  1973-02       Impact factor: 3.346

6.  Visualization of a high protein concentration in the cochlea of a patient with a large endolymphatic duct and sac, using three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging.

Authors:  M Sugiura; S Naganawa; E Sato; T Nakashima
Journal:  J Laryngol Otol       Date:  2006-09-25       Impact factor: 1.469

7.  Biochemical studies of inner ear fluid in man. Changes in otosclerosis, Meniere's disease, and acoustic neuroma.

Authors:  H Silverstein; H F Schuknecht
Journal:  Arch Otolaryngol       Date:  1966-10

8.  Antigenicity and protein content of perilymph in acoustic neuroma patients.

Authors:  N Rasmussen; K Bendtzen; J Thomsen; M Tos
Journal:  Acta Otolaryngol       Date:  1984 May-Jun       Impact factor: 1.494

9.  Electrophoretic separation and identification of perilymph proteins in cases of acoustic neuroma.

Authors:  A F O'Connor; L M Luxon; R C Shortman; E J Thompson; A W Morrison
Journal:  Acta Otolaryngol       Date:  1982       Impact factor: 1.494

10.  Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

View more
  9 in total

Review 1.  The Management and Imaging of Vestibular Schwannomas.

Authors:  E P Lin; B T Crane
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-25       Impact factor: 3.825

2.  MRI of endolymphatic hydrops in patients with vestibular schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3 Teslas.

Authors:  Aurélie Karch-Georges; Francis Veillon; Hella Vuong; Dominique Rohmer; Anne Karol; Anne Charpiot; Nicolas Meyer; Aina Venkatasamy
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-27       Impact factor: 2.503

3.  Relationship between Signal Intensity of the Labyrinth and Cochleovestibular Testing and Morphologic Features of Vestibular Schwannoma.

Authors:  Felipe Constanzo; Bernardo Corrêa de Almeida Teixeira; Patricia Sens; Dante Escuissato; Ricardo Ramina
Journal:  J Neurol Surg B Skull Base       Date:  2021-03-08

4.  Diagnostic value and prognostic significance of MRI findings in sudden sensorineural hearing loss.

Authors:  Jelena Todic; Nils Guinand; Vincent Lenoir; Pascal Senn; Minerva Becker
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-15

5.  Brainstem hyperintensity in patients with vestibular schwannoma is associated with labyrinth signal on magnetic resonance imaging but not vestibulocochlear tests.

Authors:  Bernardo Corrêa de Almeida Teixeira; Felipe Constanzo; Patricia Sens; Ricardo Ramina; Dante Luiz Escuissato
Journal:  Neuroradiol J       Date:  2020-12-16

6.  Differentiation of vestibular schwannomas from meningiomas of the internal auditory canal using perilymphatic signal evaluation on T2-weighted gradient-echo fast imaging employing steady state acquisition at 3T.

Authors:  A Venkatasamy; D Le Foll; A Karol; B Lhermitte; A Charpiot; C Debry; F Proust; N Meyer; F Veillon
Journal:  Eur Radiol Exp       Date:  2017-06-29

7.  Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review.

Authors:  Jinlu Gan; Yanling Zhang; Jingnan Wu; Deqiang Lei; Fangcheng Zhang; Hongyang Zhao; Lei Wang
Journal:  Front Oncol       Date:  2021-08-12       Impact factor: 6.244

Review 8.  Biomarkers in Vestibular Schwannoma-Associated Hearing Loss.

Authors:  Luis Lassaletta; Miryam Calvino; Jose Manuel Morales-Puebla; Pablo Lapunzina; Lourdes Rodriguez-de la Rosa; Isabel Varela-Nieto; Victor Martinez-Glez
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

9.  Signal and morphological changes in the endolymph of patients with vestibular schwannoma on non-contrast 3D FLAIR at 3 Tesla.

Authors:  Iichiro Osawa; Eito Kozawa; Sayuri Tanaka; Akane Kaizu; Kaiji Inoue; Tetsuo Ikezono; Takamitsu Fujimaki; Mamoru Niitsu
Journal:  BMC Med Imaging       Date:  2021-09-25       Impact factor: 1.930

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.